← Back to Search

Prostaglandin Analog

Excimer laser for Vitiligo

Phase < 1
Waitlist Available
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All patients 18 years and older with the diagnosis of Vitiligo.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 12
Awards & highlights

Study Summary

This trial aims to treat vitiligo with a combination of topical PGF2α, microneedling and excimer laser, with the goal of better repigmentation than the standard of care after 12 weeks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of patients with perceived improvement after 12 weeks.
Percentage of skin repigmentation after 12 weeks
Secondary outcome measures
Change in quality of life

Side effects data

From 2016 Phase 4 trial • 379 Patients • NCT02017327
1%
breast neoplasm
1%
intervetebral disk protrusion
1%
prostate cancer
100%
80%
60%
40%
20%
0%
Study treatment Arm
Monoprost
Lumigan 0.01%
Lumigan 0.03% Unit Dose

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Area 1: Excimer laser, bimatoprost, and microneedlingExperimental Treatment3 Interventions
Group II: Area 2: Excimer laserActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bimatoprost
2018
Completed Phase 4
~3930
Excimer laser
2021
Completed Early Phase 1
~10
Microneedling with a dermaroller
2021
Completed Early Phase 1
~10

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor
933 Previous Clinical Trials
7,394,631 Total Patients Enrolled
1 Trials studying Vitiligo
20 Patients Enrolled for Vitiligo

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Effect of Microneedling, Bimatoprost and Excimer in Vitiligo Treatment
Joni Mazza Mccrann 2021. "Effect of Microneedling, Bimatoprost and Excimer in Vitiligo Treatment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04738149.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top